Frequently Asked Questions > COVID-19 > Clinical Trial Testing
COVID-19 Clinical Trial Testing
Since BioPharma Diagnostics uses a common code for COVID-19 testing, can I direct my samples for testing to a specific platform? Or will the samples be tested by a mix of platforms?
At this time, testing can only be directed to the Roche 6800/8800 platform. If a common code is used, the results are reported with a comment stating the platform and reagents used.
Can I obtain cycle threshold (Ct) values with the results?
Does BioPharma Diagnostics offer a test for COVID-19 viral load?
Yes. Testing is by Bio-Rad Laboratories for SARS-CoV-2 on the QX200 and QXDx Droplet Digital PCR (ddPCR) Systems. This is a quantitative test.
What antibody type is measured? What is the antibody directed toward?
The Ortho Clinical Diagnostics assay is an IgG directed toward the SARS-CoV-2-spike protein.
Does BioPharma Diagnostics offer a quantitative serology test?
No. However, a signal-to-cutoff (S/Co) ratio can be provided as a semi-quantitative value for an additional fee.
What other serology tests are available?
BioPharma Diagnostics has a qualitative serology antibody test that is total antibody and directed toward the SARS-CoV-2 nucleocapsid protein. This test is performed using the Roche Elecsys platform.